Osteopore Ltd (OSX) - Total Assets
Based on the latest financial reports, Osteopore Ltd (OSX) holds total assets worth AU$4.19 Million AUD (≈ $2.97 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Osteopore Ltd for net asset value and shareholders' equity analysis.
Osteopore Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Osteopore Ltd's total assets have evolved over time, based on quarterly financial data.
Osteopore Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Osteopore Ltd's total assets of AU$4.19 Million consist of 75.0% current assets and 25.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 20.4% |
| Accounts Receivable | AU$1.07 Million | 34.1% |
| Inventory | AU$379.51K | 12.1% |
| Property, Plant & Equipment | AU$322.51K | 10.3% |
| Intangible Assets | AU$461.86K | 14.7% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Osteopore Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OSX market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Osteopore Ltd's current assets represent 75.0% of total assets in 2024, a decrease from 75.6% in 2016.
- Cash Position: Cash and equivalents constituted 20.4% of total assets in 2024, up from 3.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 34.1% of total assets.
Osteopore Ltd Competitors by Total Assets
Key competitors of Osteopore Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Teleflex Incorporated
NYSE:TFX
|
USA | $6.95 Billion |
|
Touchstone International Medical Science Co Ltd
SHG:688013
|
China | CN¥676.02 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
Crossject
PA:ALCJ
|
France | €31.38 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
Osteopore Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.22 | 1.36 | 2.36 |
| Quick Ratio | 1.11 | 1.25 | 2.31 |
| Cash Ratio | 0.59 | 0.81 | 0.00 |
| Working Capital | AU$663.50K | AU$994.07K | AU$1.78 Million |
Osteopore Ltd - Advanced Valuation Insights
This section examines the relationship between Osteopore Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.36 |
| Latest Market Cap to Assets Ratio | 0.76 |
| Asset Growth Rate (YoY) | -6.2% |
| Total Assets | AU$3.13 Million |
| Market Capitalization | $2.39 Million USD |
Valuation Analysis
Below Book Valuation: The market values Osteopore Ltd's assets below their book value (0.76x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Osteopore Ltd's assets decreased by 6.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Osteopore Ltd (2016–2024)
The table below shows the annual total assets of Osteopore Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$3.13 Million ≈ $2.22 Million |
-6.23% |
| 2023-12-31 | AU$3.34 Million ≈ $2.37 Million |
-7.66% |
| 2022-12-31 | AU$3.62 Million ≈ $2.56 Million |
-39.72% |
| 2021-12-31 | AU$6.01 Million ≈ $4.25 Million |
-41.39% |
| 2020-12-31 | AU$10.25 Million ≈ $7.25 Million |
+139.16% |
| 2019-12-31 | AU$4.28 Million ≈ $3.03 Million |
-20.68% |
| 2018-12-31 | AU$5.40 Million ≈ $3.82 Million |
+1445.09% |
| 2017-12-31 | AU$349.61K ≈ $247.37K |
-59.29% |
| 2016-12-31 | AU$858.80K ≈ $607.66K |
-- |
About Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more